Bristol Myers offloading Swiss tablet and capsule plant to Chinese CDMO WuXi STA

WuXi Biologics spent 2020 laying out manufacturing expansions left and right. Now, another CDMO under the WuXi umbrella is getting in on the action.

WuXi AppTec subsidiary STA Pharmaceutical, also known as WuXi STA, plans to buy a Bristol Myers Squibb tablet and capsule production plant in Couvet, Switzerland, the parties said Tuesday. If the deal closes in the second quarter as planned, WuXi STA will take over operations at the plant, snaring equipment as well as the current Couvet workforce.